OLOPATADINE 5mg. IP

An anti-allergic medicine that treats allergic disorders such as urticaria, rhinitis, and atopic dermatitis. (Teruhiko Makino, 2012) Exerts more rapid and prolonged antihistaminic effects in comparison with other second-generation antihistamines. (Teruhiko Makino, 2012) A beneficial agent that provides long-lasting symptom relief for chronic urticaria patients. (Teruhiko Makino, 2012) Suppresses the production and release of inflammatory substances in the body which cause allergic symptoms. (Jae Hoon Kim, 2021) A beneficial medication that shows prompt alleviation of pruritus in urticaria. (Mariko Niide, 2006) Produces a significant reduction in the wheal and flare responses induced by histamine. (Hiroyuki Kamei, 2012) An effective and safe therapeutic option for perennial allergic rhinitis in children. (Kimihiro Okubo, 2010) Shows a rapid and long-lasting inhibitory effect on the histamine-induced skin response. (Hiroyuki Kamei, 2012) Significantly ameliorates sneezing, rhinorrhea, and nasal congestion in children aged 7 to 16 years with perennial allergic rhinitis. (Kimihiro Okubo, 2010) A safe and more effective alternative to levocetirizine in the treatment of chronic urticaria. (Amrita Sil, 2013) A viable alternative or addition to first-line therapies such as intranasal steroids and oral antihistamines. (Alexei Gonzalez-Estrada, 2017)